Your browser doesn't support javascript.
loading
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
Chertow, Glenn M; Appel, Gerald B; Andreoli, Sharon; Bangalore, Sripal; Block, Geoffrey A; Chapman, Arlene B; Chin, Melanie P; Gibson, Keisha L; Goldsberry, Angie; Iijima, Kazumoto; Inker, Lesley A; Knebelmann, Bertrand; Mariani, Laura H; Meyer, Colin J; Nozu, Kandai; O'Grady, Megan; Silva, Arnold L; Stenvinkel, Peter; Torra, Roser; Warady, Bradley A; Pergola, Pablo E.
Afiliación
  • Chertow GM; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
  • Appel GB; Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA.
  • Andreoli S; Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Bangalore S; Cardiovascular Clinical Research Center, New York University School of Medicine, New York, New York, USA.
  • Block GA; Department of Clinical Research and Medical Affairs, US Renal Care, Inc., Plano, Texas, USA.
  • Chapman AB; Section of Nephrology, University of Chicago, Chicago, Illinois, USA.
  • Chin MP; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.
  • Gibson KL; University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Goldsberry A; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.
  • Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Inker LA; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.
  • Knebelmann B; Department of Nephrology, Necker Hospital, AP-HP, Université de Paris, Paris, France.
  • Mariani LH; Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
  • Meyer CJ; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.
  • Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
  • O'Grady M; Department of Product Development, Reata Pharmaceuticals, Plano, Texas, USA.
  • Silva AL; Boise Kidney and Hypertension Institute, Meridian, Idaho, USA.
  • Stenvinkel P; Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.
  • Torra R; Inherited Kidney Disorders, Nephrology Department, Fundacio Puigvert, Instituto de Investigacion Carlos III, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Warady BA; Division of Pediatric Nephrology, Children's Mercy Kansas City, Kansas City, Missouri, USA.
  • Pergola PE; Renal Associates PA, San Antonio, Texas, USA.
Am J Nephrol ; 52(3): 180-189, 2021.
Article en En | MEDLINE | ID: mdl-33789284
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácido Oleanólico / Nefritis Hereditaria Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Nephrol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácido Oleanólico / Nefritis Hereditaria Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Nephrol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos